TheraVet SA (ALVET.PA)

0.7900 +0.0120 (+1.54%) At close: 01:11PM CEST

TheraVet SA

Avenue Jean Mermoz 32/1
Gosselies
Charleroi 6041
Belgium

https://www.thera.vet/en

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 7

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Enrico Bastianelli M.B.A., M.D., MBA	Founder, CEO & Director	N/A	N/A	1969
Mr. Rodolphe Lebrun	Chief Financial Officer	N/A	N/A	N/A
Ms. Sabrina Ena Ph.D.	Chief Operating Officer	N/A	N/A	N/A
Fanny Guillerminet	Managing Director of the US	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

TheraVet SA, a veterinary biotechnology company, provides osteoarticular treatments for animals in Belgium, France, Switzerland, the United Kingdom, and the United States. The company primarily provides products for osteoarthritis, ligament and tendon injuries, and bone surgery in cats, dogs, and horses. It offers BIOCERA-VET, an injectable self-hardening phosphocalcic bone void filler for osteointegration, osteoinduction, and bone remodeling properties; and VISCO-VET, an injectable visco-regenerative gel based on hyaluronic acid, species specific plasma, and an active pharmaceutical component. The company also provides various products, such as BIOCERA-VET bone surgery RTU, a ready-to-use highly injectable self-hardening calcium-phosphate cement; BIOCERA-VET smartgraft, a naturally osteoconductive bone graft; BIOCERA-VET granules, an affordable biocompatible calcium-phosphate bone substitute; and BIOCERA-VET osteosarcoma RTU, a ready-to-use highly injectable calcium-phosphate bone substitute for cementoplasty. TheraVet SA was incorporated in 2017 and is based in Gosselies, Belgium.

Corporate governance

TheraVet SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.